| 1 | admission | 8,317 |
| 2 | admissions | 2,399 |
| 3 | arrival | 692 |
| 4 | awakening | 431 |
| 5 | weekends | 109 |
| 6 | admittance | 78 |
| 7 | length-of-stay | 40 |
| 8 | tyne | 22 |
| 9 | mondays | 14 |
| 10 | photoexcitation | 14 |
| 11 | e19 | 11 |
| 12 | saturdays | 10 |
| 13 | admittances | 9 |
| 14 | sedge | 7 |
| 15 | /p/ | 6 |
| 16 | gregorio | 5 |
| 17 | met-diet | 5 |
| 18 | pod+12 | 5 |
| 19 | sonolysis | 5 |
| 20 | thursdays | 5 |
| 21 | 'deaths | 4 |
| 22 | 11q23.3 | 4 |
| 23 | alcohol/drugs | 4 |
| 24 | bmj.com | 4 |
| 25 | e21 | 4 |
| 26 | fluoxetine/paroxetine | 4 |
| 27 | gd13 | 4 |
| 28 | lisinopril-nitrates | 4 |
| 29 | nogo-n200 | 4 |
| 30 | pd42 | 4 |
| 31 | readmittance | 4 |
| 32 | ser2 | 4 |
| 33 | sundays | 4 |
| 34 | tacrolimus-mmf | 4 |
| 35 | typicals | 4 |
| 36 | 19pter-p13.11 | 3 |
| 37 | 1q32.1 | 3 |
| 38 | 2d-t1 | 3 |
| 39 | 400n | 3 |
| 40 | 5α-reduction | 3 |
| 41 | admission/readmission | 3 |
| 42 | bandung | 3 |
| 43 | deae-52 | 3 |
| 44 | dna3'pp5'g | 3 |
| 45 | fsh- | 3 |
| 46 | malekula | 3 |
| 47 | p9-16 | 3 |
| 48 | reincubation | 3 |
| 49 | rtxd35 | 3 |
| 50 | ser-519 | 3 |
| 51 | silkeborg | 3 |
| 52 | tbl1wi | 3 |
| 53 | travnik | 3 |
| 54 | waterlines | 3 |
| 55 | www.cochrane.dk | 3 |
| 56 | 1/8/2007 | 2 |
| 57 | 12q24.31 | 2 |
| 58 | 19q13.42 | 2 |
| 59 | 223racl2 | 2 |
| 60 | 24/10/2013 | 2 |
| 61 | 25-hydroxylation | 2 |
| 62 | 34d | 2 |
| 63 | 7/11/2007 | 2 |
| 64 | 7q36.3 | 2 |
| 65 | 8-lox | 2 |
| 66 | a375p | 2 |
| 67 | amygdala- | 2 |
| 68 | bicêtre | 2 |
| 69 | births/year | 2 |
| 70 | bp-based | 2 |
| 71 | calcining | 2 |
| 72 | chr15q21.2-22.3 | 2 |
| 73 | clinicohemodynamic | 2 |
| 74 | cubozoans | 2 |
| 75 | dbest | 2 |
| 76 | fab/lmb96 | 2 |
| 77 | higher-frequency | 2 |
| 78 | itch/pruritus | 2 |
| 79 | krefeld | 2 |
| 80 | lg4 | 2 |
| 81 | lg6 | 2 |
| 82 | nmda-receptors | 2 |
| 83 | pbd7 | 2 |
| 84 | pgb-300/450 | 2 |
| 85 | photoillumination | 2 |
| 86 | pilsen | 2 |
| 87 | proud2bme | 2 |
| 88 | pseudobulbs | 2 |
| 89 | snicking | 2 |
| 90 | spid-3 | 2 |
| 91 | sprat | 2 |
| 92 | sylvanus | 2 |
| 93 | t1619 | 2 |
| 94 | torreon | 2 |
| 95 | troopships | 2 |
| 96 | tyr-300 | 2 |
| 97 | unguis | 2 |
| 98 | wa'ab | 2 |
| 99 | 'lidocaine | 1 |
| 100 | 'psychopharmacotherapy | 1 |
| 101 | 'sympathectomy | 1 |
| 102 | -80ºc | 1 |
| 103 | 01-10-2012 | 1 |
| 104 | 01/08/2003 | 1 |
| 105 | 04/08/2006 | 1 |
| 106 | 05/05/2000 | 1 |
| 107 | 1,2,4-orthoacetylglucose | 1 |
| 108 | 1,3-dipalmitoyl-2-oleoyl-glycerol | 1 |
| 109 | 1,3-propandiol | 1 |
| 110 | 1,5-hexadiene | 1 |
| 111 | 1,7,14 | 1 |
| 112 | 1.18-sieve | 1 |
| 113 | 11-9-2007 | 1 |
| 114 | 11/02/10 | 1 |
| 115 | 11/10/2005 | 1 |
| 116 | 11/10/2013 | 1 |
| 117 | 11/9/2006 | 1 |
| 118 | 12/06/02 | 1 |
| 119 | 12/11/2007 | 1 |
| 120 | 12/2/2008 | 1 |
| 121 | 12/5/2008 | 1 |
| 122 | 12p24.31 | 1 |
| 123 | 13.12.2013 | 1 |
| 124 | 14-3-3χ | 1 |
| 125 | 14q32.33 | 1 |
| 126 | 15q13 | 1 |
| 127 | 18/06/13 | 1 |
| 128 | 1ha | 1 |
| 129 | 1p22 | 1 |
| 130 | 2,3,4- | 1 |
| 131 | 2,3-bdo-biosynthesis | 1 |
| 132 | 2/8/2006 | 1 |
| 133 | 2/9/2005 | 1 |
| 134 | 20-pound | 1 |
| 135 | 2012/03/06 | 1 |
| 136 | 2012/03/20 | 1 |
| 137 | 21-10-2005 | 1 |
| 138 | 21/10/2005 | 1 |
| 139 | 21/10/2011 | 1 |
| 140 | 21/6/2006 | 1 |
| 141 | 21q | 1 |
| 142 | 25/4/2005 | 1 |
| 143 | 28-11-2005 | 1 |
| 144 | 28/03/2006 | 1 |
| 145 | 29-nov-2013 | 1 |
| 146 | 2mr-qff | 1 |
| 147 | 3'amp | 1 |
| 148 | 3.0tmri | 1 |
| 149 | 3/8/2005 | 1 |
| 150 | 30/11/1995 | 1 |
| 151 | 30w | 1 |
| 152 | 31/07/2011 | 1 |
| 153 | 31/10/2012 | 1 |
| 154 | 395nm | 1 |
| 155 | 3bs | 1 |
| 156 | 4,352 | 1 |
| 157 | 4-ohe2- | 1 |
| 158 | 4q13-3q5 | 1 |
| 159 | 5,375 | 1 |
| 160 | 5-9-2005 | 1 |
| 161 | 6f- | 1 |
| 162 | 6q25.2-6q26 | 1 |
| 163 | 7/8/2007 | 1 |
| 164 | 7p13 | 1 |
| 165 | 7p15.2 | 1 |
| 166 | 7p22.2 | 1 |
| 167 | 8p23.1 | 1 |
| 168 | 8q22 | 1 |
| 169 | abdominalgia | 1 |
| 170 | abstract/title | 1 |
| 171 | acetogenesis | 1 |
| 172 | acetylcholine-stimulation | 1 |
| 173 | adfi/adg | 1 |
| 174 | admission/initial | 1 |
| 175 | aerotherapy | 1 |
| 176 | aging-funded | 1 |
| 177 | alloresponsiveness | 1 |
| 178 | alzheimer-pathology | 1 |
| 179 | angiohistogram | 1 |
| 180 | anti-senility | 1 |
| 181 | antibiotic-dispensing | 1 |
| 182 | atc-lab | 1 |
| 183 | atherosclerosis-safety | 1 |
| 184 | atheroslocerosis | 1 |
| 185 | balance-control | 1 |
| 186 | beauticians | 1 |
| 187 | behavior-i.e | 1 |
| 188 | behavioral-performance | 1 |
| 189 | behaviorally- | 1 |
| 190 | benzodiazepines/hypnotics | 1 |
| 191 | biaised | 1 |
| 192 | bioautogram | 1 |
| 193 | biothermokinetics | 1 |
| 194 | bitter-cup | 1 |
| 195 | brca-mutations | 1 |
| 196 | bremelanotide | 1 |
| 197 | c.p.l.m | 1 |
| 198 | c9344 | 1 |
| 199 | cancer/union | 1 |
| 200 | candida-uti | 1 |
| 201 | carm-1 | 1 |
| 202 | case-detection | 1 |
| 203 | catherterization | 1 |
| 204 | cd14+-monocytes | 1 |
| 205 | chemist/engineers | 1 |
| 206 | chitin/chitosan | 1 |
| 207 | chr17q | 1 |
| 208 | cigarettes/alcohol | 1 |
| 209 | clorin | 1 |
| 210 | cmv-infections | 1 |
| 211 | cmv-prophylaxis | 1 |
| 212 | copd-symptoms | 1 |
| 213 | corel5k | 1 |
| 214 | corticosteroid-oral | 1 |
| 215 | crosssection | 1 |
| 216 | cryotops | 1 |
| 217 | culture-contamination | 1 |
| 218 | cyromazine- | 1 |
| 219 | cystoreduction | 1 |
| 220 | cytology/pathology | 1 |
| 221 | d8-d13 | 1 |
| 222 | darunavir/monotherapy | 1 |
| 223 | days1-5 | 1 |
| 224 | dehydration/dehydroxylation | 1 |
| 225 | dejguny | 1 |
| 226 | delay/nondelay | 1 |
| 227 | depot-risperidone | 1 |
| 228 | design-copying | 1 |
| 229 | dha-metabolites | 1 |
| 230 | disclosure- | 1 |
| 231 | dithienobenzothiadiazole | 1 |
| 232 | dna-expression | 1 |
| 233 | downward- | 1 |
| 234 | dp=30 | 1 |
| 235 | drapalib | 1 |
| 236 | driver-athletes | 1 |
| 237 | drug-abstinence | 1 |
| 238 | dysco₃ | 1 |
| 239 | e-/ts | 1 |
| 240 | ebm-criteria | 1 |
| 241 | eca1 | 1 |
| 242 | eca7 | 1 |
| 243 | echo-ecg | 1 |
| 244 | ed10 | 1 |
| 245 | endonucleolysis | 1 |
| 246 | entrepreneurialism | 1 |
| 247 | erythropoietin-hyporesponsive | 1 |
| 248 | esrfs | 1 |
| 249 | estradiol- | 1 |
| 250 | estradiol-3- | 1 |
| 251 | ethnoclassification | 1 |
| 252 | extrelut® | 1 |
| 253 | fcr3 | 1 |
| 254 | ffpe-sections | 1 |
| 255 | fibrocartilages | 1 |
| 256 | fibronectin- | 1 |
| 257 | flhclabor | 1 |
| 258 | flight- | 1 |
| 259 | floodplains | 1 |
| 260 | folk-categories | 1 |
| 261 | fortison | 1 |
| 262 | four-month-infants | 1 |
| 263 | foxh1 | 1 |
| 264 | functional-reach | 1 |
| 265 | funding/coi | 1 |
| 266 | fxed | 1 |
| 267 | gallnut | 1 |
| 268 | gc/tofms | 1 |
| 269 | gcc- | 1 |
| 270 | gd13.5 | 1 |
| 271 | gd135 | 1 |
| 272 | gd18 | 1 |
| 273 | gedvcorrected | 1 |
| 274 | gelfiltration | 1 |
| 275 | glargine- | 1 |
| 276 | glectin-3 | 1 |
| 277 | gm-csf- | 1 |
| 278 | gp-oxidase | 1 |
| 279 | gpm/grp | 1 |
| 280 | gpt/pgb | 1 |
| 281 | gre/1 | 1 |
| 282 | guglielmi | 1 |
| 283 | h-day | 1 |
| 284 | hadm17 | 1 |
| 285 | ham-d,5 | 1 |
| 286 | hcl/etoh | 1 |
| 287 | hdm-ait | 1 |
| 288 | hematogenesis | 1 |
| 289 | hemochrome | 1 |
| 290 | heteropathy | 1 |
| 291 | hot-melt-extrudates | 1 |
| 292 | housemaids | 1 |
| 293 | hs700t | 1 |
| 294 | hu133_plus_2.0 | 1 |
| 295 | hvlt-i | 1 |
| 296 | hydroxyprolinuria | 1 |
| 297 | hyperglycosemia | 1 |
| 298 | hyperspasticity | 1 |
| 299 | hypofractioning | 1 |
| 300 | hypostome | 1 |
| 301 | hysterosonography | 1 |
| 302 | i.v.p | 1 |
| 303 | iciq-scores | 1 |
| 304 | iess-ii | 1 |
| 305 | ifn-τ | 1 |
| 306 | ifnß | 1 |
| 307 | immulite-1000 | 1 |
| 308 | incarnation | 1 |
| 309 | independently-confirmed | 1 |
| 310 | inflammageing | 1 |
| 311 | injured-neurons | 1 |
| 312 | instigative | 1 |
| 313 | intentions/motives | 1 |
| 314 | intruder- | 1 |
| 315 | israelites | 1 |
| 316 | ivdmd | 1 |
| 317 | j-774 | 1 |
| 318 | jcpyv/vp1 | 1 |
| 319 | jund- | 1 |
| 320 | kap95 | 1 |
| 321 | kloo | 1 |
| 322 | kv4.1 | 1 |
| 323 | la0.7-yca0.3+ymn1-yruyo3 | 1 |
| 324 | landforms | 1 |
| 325 | lanmen | 1 |
| 326 | ld/cd | 1 |
| 327 | lg08 | 1 |
| 328 | linux | 1 |
| 329 | lipoproteins/lipids | 1 |
| 330 | local/vernacular | 1 |
| 331 | low-effort | 1 |
| 332 | lpa- | 1 |
| 333 | lucidin | 1 |
| 334 | lys104 | 1 |
| 335 | lys99 | 1 |
| 336 | m.n. | 1 |
| 337 | m.robertsii | 1 |
| 338 | maconkey | 1 |
| 339 | macroeconomics | 1 |
| 340 | macrophages/neutrophils | 1 |
| 341 | macroscales | 1 |
| 342 | mangers | 1 |
| 343 | marketability | 1 |
| 344 | marx-leninism | 1 |
| 345 | maternal/paternal | 1 |
| 346 | mc-coa | 1 |
| 347 | mcp-1- | 1 |
| 348 | mdma- | 1 |
| 349 | medline-ime | 1 |
| 350 | melamine-formaldehyde | 1 |
| 351 | meltdose-technique | 1 |
| 352 | met-27 | 1 |
| 353 | mg-compounds | 1 |
| 354 | microcontrollers | 1 |
| 355 | mindlines-internalised | 1 |
| 356 | mk-0731 | 1 |
| 357 | mk-7009+pegifn | 1 |
| 358 | mlo-images | 1 |
| 359 | mo-pyranopterin | 1 |
| 360 | modeling/voi | 1 |
| 361 | motion/tenderness | 1 |
| 362 | movement/cough | 1 |
| 363 | mr29072 | 1 |
| 364 | mra/ia | 1 |
| 365 | mrp3- | 1 |
| 366 | multi-regulation | 1 |
| 367 | multimodality-derived | 1 |
| 368 | myspace.com | 1 |
| 369 | na+/k+- | 1 |
| 370 | need/acceptability | 1 |
| 371 | nefhropathy | 1 |
| 372 | neuroacanthocytosis | 1 |
| 373 | neuroactivity | 1 |
| 374 | neuroimmunopharmacology | 1 |
| 375 | nights/weekends | 1 |
| 376 | nnewi | 1 |
| 377 | non-competent | 1 |
| 378 | o'ahu | 1 |
| 379 | o-nitrophenyl-β-d-galactopyranoside | 1 |
| 380 | oct2- | 1 |
| 381 | operator-experience | 1 |
| 382 | ophiuroids | 1 |
| 383 | opsr | 1 |
| 384 | oxamate-agarose | 1 |
| 385 | oxazolidinedione | 1 |
| 386 | oxidation- | 1 |
| 387 | p-crkl | 1 |
| 388 | p-glycloprotein | 1 |
| 389 | p110α- | 1 |
| 390 | palpation/manipulation | 1 |
| 391 | panlobular | 1 |
| 392 | panss-pss | 1 |
| 393 | participation/adherence | 1 |
| 394 | partner-testing | 1 |
| 395 | pbas2 | 1 |
| 396 | pc-286,386,486 | 1 |
| 397 | pczl | 1 |
| 398 | pentagastrin-stimulation | 1 |
| 399 | per-ecg | 1 |
| 400 | pharmacognostics | 1 |
| 401 | physical-cardiovascular | 1 |
| 402 | pka/pkcε | 1 |
| 403 | plaque-growth | 1 |
| 404 | pod+7 | 1 |
| 405 | pod0 | 1 |
| 406 | pod30 | 1 |
| 407 | pod6 | 1 |
| 408 | polyalcohols | 1 |
| 409 | post-prandial- | 1 |
| 410 | pre-infestation | 1 |
| 411 | pre-travel-vaccinations | 1 |
| 412 | predonine | 1 |
| 413 | preimplantational | 1 |
| 414 | prescription-symptom-dosage | 1 |
| 415 | prevalences/incidences | 1 |
| 416 | psychophysic | 1 |
| 417 | pten/p53status | 1 |
| 418 | ptl/ptb | 1 |
| 419 | ptyb1 | 1 |
| 420 | punishment- | 1 |
| 421 | quantitatively- | 1 |
| 422 | r-219/221 | 1 |
| 423 | rad1 | 1 |
| 424 | re/nerd | 1 |
| 425 | reptilians | 1 |
| 426 | respectiverly | 1 |
| 427 | reward/addiction | 1 |
| 428 | ria-rga | 1 |
| 429 | room/nursing | 1 |
| 430 | rtxd56 | 1 |
| 431 | s-components | 1 |
| 432 | salt/nephrectomy | 1 |
| 433 | saturdays/sundays | 1 |
| 434 | schizophrenia- | 1 |
| 435 | sds-pge | 1 |
| 436 | sec24c | 1 |
| 437 | sensitivity/acceptability | 1 |
| 438 | ser-139 | 1 |
| 439 | ser380 | 1 |
| 440 | ser465 | 1 |
| 441 | seromaformation | 1 |
| 442 | setting-were | 1 |
| 443 | skateboards | 1 |
| 444 | skin-grafts | 1 |
| 445 | slacklines | 1 |
| 446 | so.ge.pa | 1 |
| 447 | src/fak | 1 |
| 448 | sro- | 1 |
| 449 | srs2 | 1 |
| 450 | stable-art | 1 |
| 451 | stai-jyz | 1 |
| 452 | stoppler | 1 |
| 453 | sub-domain-level | 1 |
| 454 | surrealism | 1 |
| 455 | sympatho-activation | 1 |
| 456 | t249 | 1 |
| 457 | tcp/ip | 1 |
| 458 | tdcs- | 1 |
| 459 | thin-shelled | 1 |
| 460 | ti-tisi2 | 1 |
| 461 | time-to-wound-healing | 1 |
| 462 | tiptoes | 1 |
| 463 | tnf-sepharose | 1 |
| 464 | traditionalhealers | 1 |
| 465 | trainee-trainer | 1 |
| 466 | trbd-i-ii | 1 |
| 467 | trpa1- | 1 |
| 468 | trypsin-treated | 1 |
| 469 | ttr-levels | 1 |
| 470 | tuesdays | 1 |
| 471 | typability | 1 |
| 472 | tyr110 | 1 |
| 473 | tyr960 | 1 |
| 474 | ukall97 | 1 |
| 475 | underdoping | 1 |
| 476 | updrs-ivb | 1 |
| 477 | uplc-dad/q-tof-ms | 1 |
| 478 | urea-modified | 1 |
| 479 | urea-page | 1 |
| 480 | urticara | 1 |
| 481 | uvo-treatment | 1 |
| 482 | vaniprevir/p/r | 1 |
| 483 | ve-vo2 | 1 |
| 484 | veloergometer | 1 |
| 485 | viscerperception | 1 |
| 486 | weightloss | 1 |
| 487 | wl-furl | 1 |
| 488 | www.aawconline.org | 1 |
| 489 | www.oxynet.org | 1 |
| 490 | zocdoc.com | 1 |
| 491 | β-glycerolphosphate | 1 |
| 1 | 'deaths | 4 |
| 2 | 'lidocaine | 1 |
| 3 | 'psychopharmacotherapy | 1 |
| 4 | 'sympathectomy | 1 |
| 5 | -80ºc | 1 |
| 6 | /p/ | 6 |
| 7 | 01-10-2012 | 1 |
| 8 | 01/08/2003 | 1 |
| 9 | 04/08/2006 | 1 |
| 10 | 05/05/2000 | 1 |
| 11 | 1,2,4-orthoacetylglucose | 1 |
| 12 | 1,3-dipalmitoyl-2-oleoyl-glycerol | 1 |
| 13 | 1,3-propandiol | 1 |
| 14 | 1,5-hexadiene | 1 |
| 15 | 1,7,14 | 1 |
| 16 | 1.18-sieve | 1 |
| 17 | 1/8/2007 | 2 |
| 18 | 11-9-2007 | 1 |
| 19 | 11/02/10 | 1 |
| 20 | 11/10/2005 | 1 |
| 21 | 11/10/2013 | 1 |
| 22 | 11/9/2006 | 1 |
| 23 | 11q23.3 | 4 |
| 24 | 12/06/02 | 1 |
| 25 | 12/11/2007 | 1 |
| 26 | 12/2/2008 | 1 |
| 27 | 12/5/2008 | 1 |
| 28 | 12p24.31 | 1 |
| 29 | 12q24.31 | 2 |
| 30 | 13.12.2013 | 1 |
| 31 | 14-3-3χ | 1 |
| 32 | 14q32.33 | 1 |
| 33 | 15q13 | 1 |
| 34 | 18/06/13 | 1 |
| 35 | 19pter-p13.11 | 3 |
| 36 | 19q13.42 | 2 |
| 37 | 1ha | 1 |
| 38 | 1p22 | 1 |
| 39 | 1q32.1 | 3 |
| 40 | 2,3,4- | 1 |
| 41 | 2,3-bdo-biosynthesis | 1 |
| 42 | 2/8/2006 | 1 |
| 43 | 2/9/2005 | 1 |
| 44 | 20-pound | 1 |
| 45 | 2012/03/06 | 1 |
| 46 | 2012/03/20 | 1 |
| 47 | 21-10-2005 | 1 |
| 48 | 21/10/2005 | 1 |
| 49 | 21/10/2011 | 1 |
| 50 | 21/6/2006 | 1 |
| 51 | 21q | 1 |
| 52 | 223racl2 | 2 |
| 53 | 24/10/2013 | 2 |
| 54 | 25-hydroxylation | 2 |
| 55 | 25/4/2005 | 1 |
| 56 | 28-11-2005 | 1 |
| 57 | 28/03/2006 | 1 |
| 58 | 29-nov-2013 | 1 |
| 59 | 2d-t1 | 3 |
| 60 | 2mr-qff | 1 |
| 61 | 3'amp | 1 |
| 62 | 3.0tmri | 1 |
| 63 | 3/8/2005 | 1 |
| 64 | 30/11/1995 | 1 |
| 65 | 30w | 1 |
| 66 | 31/07/2011 | 1 |
| 67 | 31/10/2012 | 1 |
| 68 | 34d | 2 |
| 69 | 395nm | 1 |
| 70 | 3bs | 1 |
| 71 | 4,352 | 1 |
| 72 | 4-ohe2- | 1 |
| 73 | 400n | 3 |
| 74 | 4q13-3q5 | 1 |
| 75 | 5,375 | 1 |
| 76 | 5-9-2005 | 1 |
| 77 | 5α-reduction | 3 |
| 78 | 6f- | 1 |
| 79 | 6q25.2-6q26 | 1 |
| 80 | 7/11/2007 | 2 |
| 81 | 7/8/2007 | 1 |
| 82 | 7p13 | 1 |
| 83 | 7p15.2 | 1 |
| 84 | 7p22.2 | 1 |
| 85 | 7q36.3 | 2 |
| 86 | 8-lox | 2 |
| 87 | 8p23.1 | 1 |
| 88 | 8q22 | 1 |
| 89 | a375p | 2 |
| 90 | abdominalgia | 1 |
| 91 | abstract/title | 1 |
| 92 | acetogenesis | 1 |
| 93 | acetylcholine-stimulation | 1 |
| 94 | adfi/adg | 1 |
| 95 | admission | 8,317 |
| 96 | admission/initial | 1 |
| 97 | admission/readmission | 3 |
| 98 | admissions | 2,399 |
| 99 | admittance | 78 |
| 100 | admittances | 9 |
| 101 | aerotherapy | 1 |
| 102 | aging-funded | 1 |
| 103 | alcohol/drugs | 4 |
| 104 | alloresponsiveness | 1 |
| 105 | alzheimer-pathology | 1 |
| 106 | amygdala- | 2 |
| 107 | angiohistogram | 1 |
| 108 | anti-senility | 1 |
| 109 | antibiotic-dispensing | 1 |
| 110 | arrival | 692 |
| 111 | atc-lab | 1 |
| 112 | atherosclerosis-safety | 1 |
| 113 | atheroslocerosis | 1 |
| 114 | awakening | 431 |
| 115 | balance-control | 1 |
| 116 | bandung | 3 |
| 117 | beauticians | 1 |
| 118 | behavior-i.e | 1 |
| 119 | behavioral-performance | 1 |
| 120 | behaviorally- | 1 |
| 121 | benzodiazepines/hypnotics | 1 |
| 122 | biaised | 1 |
| 123 | bicêtre | 2 |
| 124 | bioautogram | 1 |
| 125 | biothermokinetics | 1 |
| 126 | births/year | 2 |
| 127 | bitter-cup | 1 |
| 128 | bmj.com | 4 |
| 129 | bp-based | 2 |
| 130 | brca-mutations | 1 |
| 131 | bremelanotide | 1 |
| 132 | c.p.l.m | 1 |
| 133 | c9344 | 1 |
| 134 | calcining | 2 |
| 135 | cancer/union | 1 |
| 136 | candida-uti | 1 |
| 137 | carm-1 | 1 |
| 138 | case-detection | 1 |
| 139 | catherterization | 1 |
| 140 | cd14+-monocytes | 1 |
| 141 | chemist/engineers | 1 |
| 142 | chitin/chitosan | 1 |
| 143 | chr15q21.2-22.3 | 2 |
| 144 | chr17q | 1 |
| 145 | cigarettes/alcohol | 1 |
| 146 | clinicohemodynamic | 2 |
| 147 | clorin | 1 |
| 148 | cmv-infections | 1 |
| 149 | cmv-prophylaxis | 1 |
| 150 | copd-symptoms | 1 |
| 151 | corel5k | 1 |
| 152 | corticosteroid-oral | 1 |
| 153 | crosssection | 1 |
| 154 | cryotops | 1 |
| 155 | cubozoans | 2 |
| 156 | culture-contamination | 1 |
| 157 | cyromazine- | 1 |
| 158 | cystoreduction | 1 |
| 159 | cytology/pathology | 1 |
| 160 | d8-d13 | 1 |
| 161 | darunavir/monotherapy | 1 |
| 162 | days1-5 | 1 |
| 163 | dbest | 2 |
| 164 | deae-52 | 3 |
| 165 | dehydration/dehydroxylation | 1 |
| 166 | dejguny | 1 |
| 167 | delay/nondelay | 1 |
| 168 | depot-risperidone | 1 |
| 169 | design-copying | 1 |
| 170 | dha-metabolites | 1 |
| 171 | disclosure- | 1 |
| 172 | dithienobenzothiadiazole | 1 |
| 173 | dna-expression | 1 |
| 174 | dna3'pp5'g | 3 |
| 175 | downward- | 1 |
| 176 | dp=30 | 1 |
| 177 | drapalib | 1 |
| 178 | driver-athletes | 1 |
| 179 | drug-abstinence | 1 |
| 180 | dysco₃ | 1 |
| 181 | e-/ts | 1 |
| 182 | e19 | 11 |
| 183 | e21 | 4 |
| 184 | ebm-criteria | 1 |
| 185 | eca1 | 1 |
| 186 | eca7 | 1 |
| 187 | echo-ecg | 1 |
| 188 | ed10 | 1 |
| 189 | endonucleolysis | 1 |
| 190 | entrepreneurialism | 1 |
| 191 | erythropoietin-hyporesponsive | 1 |
| 192 | esrfs | 1 |
| 193 | estradiol- | 1 |
| 194 | estradiol-3- | 1 |
| 195 | ethnoclassification | 1 |
| 196 | extrelut® | 1 |
| 197 | fab/lmb96 | 2 |
| 198 | fcr3 | 1 |
| 199 | ffpe-sections | 1 |
| 200 | fibrocartilages | 1 |
| 201 | fibronectin- | 1 |
| 202 | flhclabor | 1 |
| 203 | flight- | 1 |
| 204 | floodplains | 1 |
| 205 | fluoxetine/paroxetine | 4 |
| 206 | folk-categories | 1 |
| 207 | fortison | 1 |
| 208 | four-month-infants | 1 |
| 209 | foxh1 | 1 |
| 210 | fsh- | 3 |
| 211 | functional-reach | 1 |
| 212 | funding/coi | 1 |
| 213 | fxed | 1 |
| 214 | gallnut | 1 |
| 215 | gc/tofms | 1 |
| 216 | gcc- | 1 |
| 217 | gd13 | 4 |
| 218 | gd13.5 | 1 |
| 219 | gd135 | 1 |
| 220 | gd18 | 1 |
| 221 | gedvcorrected | 1 |
| 222 | gelfiltration | 1 |
| 223 | glargine- | 1 |
| 224 | glectin-3 | 1 |
| 225 | gm-csf- | 1 |
| 226 | gp-oxidase | 1 |
| 227 | gpm/grp | 1 |
| 228 | gpt/pgb | 1 |
| 229 | gre/1 | 1 |
| 230 | gregorio | 5 |
| 231 | guglielmi | 1 |
| 232 | h-day | 1 |
| 233 | hadm17 | 1 |
| 234 | ham-d,5 | 1 |
| 235 | hcl/etoh | 1 |
| 236 | hdm-ait | 1 |
| 237 | hematogenesis | 1 |
| 238 | hemochrome | 1 |
| 239 | heteropathy | 1 |
| 240 | higher-frequency | 2 |
| 241 | hot-melt-extrudates | 1 |
| 242 | housemaids | 1 |
| 243 | hs700t | 1 |
| 244 | hu133_plus_2.0 | 1 |
| 245 | hvlt-i | 1 |
| 246 | hydroxyprolinuria | 1 |
| 247 | hyperglycosemia | 1 |
| 248 | hyperspasticity | 1 |
| 249 | hypofractioning | 1 |
| 250 | hypostome | 1 |
| 251 | hysterosonography | 1 |
| 252 | i.v.p | 1 |
| 253 | iciq-scores | 1 |
| 254 | iess-ii | 1 |
| 255 | ifn-τ | 1 |
| 256 | ifnß | 1 |
| 257 | immulite-1000 | 1 |
| 258 | incarnation | 1 |
| 259 | independently-confirmed | 1 |
| 260 | inflammageing | 1 |
| 261 | injured-neurons | 1 |
| 262 | instigative | 1 |
| 263 | intentions/motives | 1 |
| 264 | intruder- | 1 |
| 265 | israelites | 1 |
| 266 | itch/pruritus | 2 |
| 267 | ivdmd | 1 |
| 268 | j-774 | 1 |
| 269 | jcpyv/vp1 | 1 |
| 270 | jund- | 1 |
| 271 | kap95 | 1 |
| 272 | kloo | 1 |
| 273 | krefeld | 2 |
| 274 | kv4.1 | 1 |
| 275 | la0.7-yca0.3+ymn1-yruyo3 | 1 |
| 276 | landforms | 1 |
| 277 | lanmen | 1 |
| 278 | ld/cd | 1 |
| 279 | length-of-stay | 40 |
| 280 | lg08 | 1 |
| 281 | lg4 | 2 |
| 282 | lg6 | 2 |
| 283 | linux | 1 |
| 284 | lipoproteins/lipids | 1 |
| 285 | lisinopril-nitrates | 4 |
| 286 | local/vernacular | 1 |
| 287 | low-effort | 1 |
| 288 | lpa- | 1 |
| 289 | lucidin | 1 |
| 290 | lys104 | 1 |
| 291 | lys99 | 1 |
| 292 | m.n. | 1 |
| 293 | m.robertsii | 1 |
| 294 | maconkey | 1 |
| 295 | macroeconomics | 1 |
| 296 | macrophages/neutrophils | 1 |
| 297 | macroscales | 1 |
| 298 | malekula | 3 |
| 299 | mangers | 1 |
| 300 | marketability | 1 |
| 301 | marx-leninism | 1 |
| 302 | maternal/paternal | 1 |
| 303 | mc-coa | 1 |
| 304 | mcp-1- | 1 |
| 305 | mdma- | 1 |
| 306 | medline-ime | 1 |
| 307 | melamine-formaldehyde | 1 |
| 308 | meltdose-technique | 1 |
| 309 | met-27 | 1 |
| 310 | met-diet | 5 |
| 311 | mg-compounds | 1 |
| 312 | microcontrollers | 1 |
| 313 | mindlines-internalised | 1 |
| 314 | mk-0731 | 1 |
| 315 | mk-7009+pegifn | 1 |
| 316 | mlo-images | 1 |
| 317 | mo-pyranopterin | 1 |
| 318 | modeling/voi | 1 |
| 319 | mondays | 14 |
| 320 | motion/tenderness | 1 |
| 321 | movement/cough | 1 |
| 322 | mr29072 | 1 |
| 323 | mra/ia | 1 |
| 324 | mrp3- | 1 |
| 325 | multi-regulation | 1 |
| 326 | multimodality-derived | 1 |
| 327 | myspace.com | 1 |
| 328 | na+/k+- | 1 |
| 329 | need/acceptability | 1 |
| 330 | nefhropathy | 1 |
| 331 | neuroacanthocytosis | 1 |
| 332 | neuroactivity | 1 |
| 333 | neuroimmunopharmacology | 1 |
| 334 | nights/weekends | 1 |
| 335 | nmda-receptors | 2 |
| 336 | nnewi | 1 |
| 337 | nogo-n200 | 4 |
| 338 | non-competent | 1 |
| 339 | o'ahu | 1 |
| 340 | o-nitrophenyl-β-d-galactopyranoside | 1 |
| 341 | oct2- | 1 |
| 342 | operator-experience | 1 |
| 343 | ophiuroids | 1 |
| 344 | opsr | 1 |
| 345 | oxamate-agarose | 1 |
| 346 | oxazolidinedione | 1 |
| 347 | oxidation- | 1 |
| 348 | p-crkl | 1 |
| 349 | p-glycloprotein | 1 |
| 350 | p110α- | 1 |
| 351 | p9-16 | 3 |
| 352 | palpation/manipulation | 1 |
| 353 | panlobular | 1 |
| 354 | panss-pss | 1 |
| 355 | participation/adherence | 1 |
| 356 | partner-testing | 1 |
| 357 | pbas2 | 1 |
| 358 | pbd7 | 2 |
| 359 | pc-286,386,486 | 1 |
| 360 | pczl | 1 |
| 361 | pd42 | 4 |
| 362 | pentagastrin-stimulation | 1 |
| 363 | per-ecg | 1 |
| 364 | pgb-300/450 | 2 |
| 365 | pharmacognostics | 1 |
| 366 | photoexcitation | 14 |
| 367 | photoillumination | 2 |
| 368 | physical-cardiovascular | 1 |
| 369 | pilsen | 2 |
| 370 | pka/pkcε | 1 |
| 371 | plaque-growth | 1 |
| 372 | pod+12 | 5 |
| 373 | pod+7 | 1 |
| 374 | pod0 | 1 |
| 375 | pod30 | 1 |
| 376 | pod6 | 1 |
| 377 | polyalcohols | 1 |
| 378 | post-prandial- | 1 |
| 379 | pre-infestation | 1 |
| 380 | pre-travel-vaccinations | 1 |
| 381 | predonine | 1 |
| 382 | preimplantational | 1 |
| 383 | prescription-symptom-dosage | 1 |
| 384 | prevalences/incidences | 1 |
| 385 | proud2bme | 2 |
| 386 | pseudobulbs | 2 |
| 387 | psychophysic | 1 |
| 388 | pten/p53status | 1 |
| 389 | ptl/ptb | 1 |
| 390 | ptyb1 | 1 |
| 391 | punishment- | 1 |
| 392 | quantitatively- | 1 |
| 393 | r-219/221 | 1 |
| 394 | rad1 | 1 |
| 395 | re/nerd | 1 |
| 396 | readmittance | 4 |
| 397 | reincubation | 3 |
| 398 | reptilians | 1 |
| 399 | respectiverly | 1 |
| 400 | reward/addiction | 1 |
| 401 | ria-rga | 1 |
| 402 | room/nursing | 1 |
| 403 | rtxd35 | 3 |
| 404 | rtxd56 | 1 |
| 405 | s-components | 1 |
| 406 | salt/nephrectomy | 1 |
| 407 | saturdays | 10 |
| 408 | saturdays/sundays | 1 |
| 409 | schizophrenia- | 1 |
| 410 | sds-pge | 1 |
| 411 | sec24c | 1 |
| 412 | sedge | 7 |
| 413 | sensitivity/acceptability | 1 |
| 414 | ser-139 | 1 |
| 415 | ser-519 | 3 |
| 416 | ser2 | 4 |
| 417 | ser380 | 1 |
| 418 | ser465 | 1 |
| 419 | seromaformation | 1 |
| 420 | setting-were | 1 |
| 421 | silkeborg | 3 |
| 422 | skateboards | 1 |
| 423 | skin-grafts | 1 |
| 424 | slacklines | 1 |
| 425 | snicking | 2 |
| 426 | so.ge.pa | 1 |
| 427 | sonolysis | 5 |
| 428 | spid-3 | 2 |
| 429 | sprat | 2 |
| 430 | src/fak | 1 |
| 431 | sro- | 1 |
| 432 | srs2 | 1 |
| 433 | stable-art | 1 |
| 434 | stai-jyz | 1 |
| 435 | stoppler | 1 |
| 436 | sub-domain-level | 1 |
| 437 | sundays | 4 |
| 438 | surrealism | 1 |
| 439 | sylvanus | 2 |
| 440 | sympatho-activation | 1 |
| 441 | t1619 | 2 |
| 442 | t249 | 1 |
| 443 | tacrolimus-mmf | 4 |
| 444 | tbl1wi | 3 |
| 445 | tcp/ip | 1 |
| 446 | tdcs- | 1 |
| 447 | thin-shelled | 1 |
| 448 | thursdays | 5 |
| 449 | ti-tisi2 | 1 |
| 450 | time-to-wound-healing | 1 |
| 451 | tiptoes | 1 |
| 452 | tnf-sepharose | 1 |
| 453 | torreon | 2 |
| 454 | traditionalhealers | 1 |
| 455 | trainee-trainer | 1 |
| 456 | travnik | 3 |
| 457 | trbd-i-ii | 1 |
| 458 | troopships | 2 |
| 459 | trpa1- | 1 |
| 460 | trypsin-treated | 1 |
| 461 | ttr-levels | 1 |
| 462 | tuesdays | 1 |
| 463 | tyne | 22 |
| 464 | typability | 1 |
| 465 | typicals | 4 |
| 466 | tyr-300 | 2 |
| 467 | tyr110 | 1 |
| 468 | tyr960 | 1 |
| 469 | ukall97 | 1 |
| 470 | underdoping | 1 |
| 471 | unguis | 2 |
| 472 | updrs-ivb | 1 |
| 473 | uplc-dad/q-tof-ms | 1 |
| 474 | urea-modified | 1 |
| 475 | urea-page | 1 |
| 476 | urticara | 1 |
| 477 | uvo-treatment | 1 |
| 478 | vaniprevir/p/r | 1 |
| 479 | ve-vo2 | 1 |
| 480 | veloergometer | 1 |
| 481 | viscerperception | 1 |
| 482 | wa'ab | 2 |
| 483 | waterlines | 3 |
| 484 | weekends | 109 |
| 485 | weightloss | 1 |
| 486 | wl-furl | 1 |
| 487 | www.aawconline.org | 1 |
| 488 | www.cochrane.dk | 3 |
| 489 | www.oxynet.org | 1 |
| 490 | zocdoc.com | 1 |
| 491 | β-glycerolphosphate | 1 |
| 1 | na+/k+- | 1 |
| 2 | mcp-1- | 1 |
| 3 | trpa1- | 1 |
| 4 | 4-ohe2- | 1 |
| 5 | oct2- | 1 |
| 6 | estradiol-3- | 1 |
| 7 | mrp3- | 1 |
| 8 | 2,3,4- | 1 |
| 9 | schizophrenia- | 1 |
| 10 | amygdala- | 2 |
| 11 | mdma- | 1 |
| 12 | lpa- | 1 |
| 13 | gcc- | 1 |
| 14 | jund- | 1 |
| 15 | downward- | 1 |
| 16 | glargine- | 1 |
| 17 | cyromazine- | 1 |
| 18 | disclosure- | 1 |
| 19 | 6f- | 1 |
| 20 | gm-csf- | 1 |
| 21 | fsh- | 3 |
| 22 | post-prandial- | 1 |
| 23 | estradiol- | 1 |
| 24 | fibronectin- | 1 |
| 25 | oxidation- | 1 |
| 26 | sro- | 1 |
| 27 | intruder- | 1 |
| 28 | tdcs- | 1 |
| 29 | flight- | 1 |
| 30 | punishment- | 1 |
| 31 | quantitatively- | 1 |
| 32 | behaviorally- | 1 |
| 33 | p110α- | 1 |
| 34 | m.n. | 1 |
| 35 | /p/ | 6 |
| 36 | hu133_plus_2.0 | 1 |
| 37 | immulite-1000 | 1 |
| 38 | 05/05/2000 | 1 |
| 39 | nogo-n200 | 4 |
| 40 | tyr-300 | 2 |
| 41 | 11/02/10 | 1 |
| 42 | tyr110 | 1 |
| 43 | ed10 | 1 |
| 44 | 2012/03/20 | 1 |
| 45 | dp=30 | 1 |
| 46 | pod30 | 1 |
| 47 | pgb-300/450 | 2 |
| 48 | tyr960 | 1 |
| 49 | ser380 | 1 |
| 50 | pod0 | 1 |
| 51 | carm-1 | 1 |
| 52 | 1q32.1 | 3 |
| 53 | 8p23.1 | 1 |
| 54 | kv4.1 | 1 |
| 55 | gre/1 | 1 |
| 56 | 19pter-p13.11 | 3 |
| 57 | 21/10/2011 | 1 |
| 58 | 31/07/2011 | 1 |
| 59 | r-219/221 | 1 |
| 60 | e21 | 4 |
| 61 | 12p24.31 | 1 |
| 62 | 12q24.31 | 2 |
| 63 | mk-0731 | 1 |
| 64 | eca1 | 1 |
| 65 | ptyb1 | 1 |
| 66 | rad1 | 1 |
| 67 | foxh1 | 1 |
| 68 | jcpyv/vp1 | 1 |
| 69 | 2d-t1 | 3 |
| 70 | 7p22.2 | 1 |
| 71 | 7p15.2 | 1 |
| 72 | 12/06/02 | 1 |
| 73 | pod+12 | 5 |
| 74 | 01-10-2012 | 1 |
| 75 | 31/10/2012 | 1 |
| 76 | 1p22 | 1 |
| 77 | 8q22 | 1 |
| 78 | 19q13.42 | 2 |
| 79 | pd42 | 4 |
| 80 | deae-52 | 3 |
| 81 | 4,352 | 1 |
| 82 | mr29072 | 1 |
| 83 | ti-tisi2 | 1 |
| 84 | 223racl2 | 2 |
| 85 | ve-vo2 | 1 |
| 86 | ser2 | 4 |
| 87 | pbas2 | 1 |
| 88 | srs2 | 1 |
| 89 | spid-3 | 2 |
| 90 | glectin-3 | 1 |
| 91 | chr15q21.2-22.3 | 2 |
| 92 | 11q23.3 | 4 |
| 93 | 7q36.3 | 2 |
| 94 | 01/08/2003 | 1 |
| 95 | 18/06/13 | 1 |
| 96 | 29-nov-2013 | 1 |
| 97 | 13.12.2013 | 1 |
| 98 | 11/10/2013 | 1 |
| 99 | 24/10/2013 | 2 |
| 100 | d8-d13 | 1 |
| 101 | gd13 | 4 |
| 102 | 7p13 | 1 |
| 103 | 15q13 | 1 |
| 104 | 14q32.33 | 1 |
| 105 | la0.7-yca0.3+ymn1-yruyo3 | 1 |
| 106 | fcr3 | 1 |
| 107 | lys104 | 1 |
| 108 | 1,7,14 | 1 |
| 109 | c9344 | 1 |
| 110 | j-774 | 1 |
| 111 | lg4 | 2 |
| 112 | ham-d,5 | 1 |
| 113 | days1-5 | 1 |
| 114 | gd13.5 | 1 |
| 115 | 21-10-2005 | 1 |
| 116 | 28-11-2005 | 1 |
| 117 | 5-9-2005 | 1 |
| 118 | 11/10/2005 | 1 |
| 119 | 21/10/2005 | 1 |
| 120 | 25/4/2005 | 1 |
| 121 | 3/8/2005 | 1 |
| 122 | 2/9/2005 | 1 |
| 123 | gd135 | 1 |
| 124 | rtxd35 | 3 |
| 125 | ser465 | 1 |
| 126 | 5,375 | 1 |
| 127 | 30/11/1995 | 1 |
| 128 | kap95 | 1 |
| 129 | 4q13-3q5 | 1 |
| 130 | 2012/03/06 | 1 |
| 131 | 28/03/2006 | 1 |
| 132 | 21/6/2006 | 1 |
| 133 | 2/8/2006 | 1 |
| 134 | 04/08/2006 | 1 |
| 135 | 11/9/2006 | 1 |
| 136 | p9-16 | 3 |
| 137 | 6q25.2-6q26 | 1 |
| 138 | rtxd56 | 1 |
| 139 | pc-286,386,486 | 1 |
| 140 | fab/lmb96 | 2 |
| 141 | pod6 | 1 |
| 142 | lg6 | 2 |
| 143 | pod+7 | 1 |
| 144 | 11-9-2007 | 1 |
| 145 | 12/11/2007 | 1 |
| 146 | 7/11/2007 | 2 |
| 147 | 1/8/2007 | 2 |
| 148 | 7/8/2007 | 1 |
| 149 | hadm17 | 1 |
| 150 | met-27 | 1 |
| 151 | ukall97 | 1 |
| 152 | eca7 | 1 |
| 153 | pbd7 | 2 |
| 154 | 12/2/2008 | 1 |
| 155 | 12/5/2008 | 1 |
| 156 | lg08 | 1 |
| 157 | gd18 | 1 |
| 158 | ser-519 | 3 |
| 159 | t1619 | 2 |
| 160 | e19 | 11 |
| 161 | ser-139 | 1 |
| 162 | t249 | 1 |
| 163 | lys99 | 1 |
| 164 | ria-rga | 1 |
| 165 | 1ha | 1 |
| 166 | mra/ia | 1 |
| 167 | abdominalgia | 1 |
| 168 | hyperglycosemia | 1 |
| 169 | ebm-criteria | 1 |
| 170 | hydroxyprolinuria | 1 |
| 171 | malekula | 3 |
| 172 | mc-coa | 1 |
| 173 | so.ge.pa | 1 |
| 174 | urticara | 1 |
| 175 | wa'ab | 2 |
| 176 | atc-lab | 1 |
| 177 | gpt/pgb | 1 |
| 178 | drapalib | 1 |
| 179 | ptl/ptb | 1 |
| 180 | updrs-ivb | 1 |
| 181 | sec24c | 1 |
| 182 | clinicohemodynamic | 2 |
| 183 | psychophysic | 1 |
| 184 | -80ºc | 1 |
| 185 | 34d | 2 |
| 186 | ld/cd | 1 |
| 187 | aging-funded | 1 |
| 188 | urea-modified | 1 |
| 189 | thin-shelled | 1 |
| 190 | independently-confirmed | 1 |
| 191 | bp-based | 2 |
| 192 | biaised | 1 |
| 193 | mindlines-internalised | 1 |
| 194 | trypsin-treated | 1 |
| 195 | gedvcorrected | 1 |
| 196 | multimodality-derived | 1 |
| 197 | fxed | 1 |
| 198 | krefeld | 2 |
| 199 | ivdmd | 1 |
| 200 | 20-pound | 1 |
| 201 | re/nerd | 1 |
| 202 | behavior-i.e | 1 |
| 203 | behavioral-performance | 1 |
| 204 | admittance | 78 |
| 205 | readmittance | 4 |
| 206 | operator-experience | 1 |
| 207 | drug-abstinence | 1 |
| 208 | participation/adherence | 1 |
| 209 | o-nitrophenyl-β-d-galactopyranoside | 1 |
| 210 | bremelanotide | 1 |
| 211 | melamine-formaldehyde | 1 |
| 212 | urea-page | 1 |
| 213 | prescription-symptom-dosage | 1 |
| 214 | sedge | 7 |
| 215 | sds-pge | 1 |
| 216 | dithienobenzothiadiazole | 1 |
| 217 | abstract/title | 1 |
| 218 | proud2bme | 2 |
| 219 | medline-ime | 1 |
| 220 | hemochrome | 1 |
| 221 | hypostome | 1 |
| 222 | 1,5-hexadiene | 1 |
| 223 | 'lidocaine | 1 |
| 224 | predonine | 1 |
| 225 | fluoxetine/paroxetine | 4 |
| 226 | depot-risperidone | 1 |
| 227 | oxazolidinedione | 1 |
| 228 | tyne | 22 |
| 229 | setting-were | 1 |
| 230 | bicêtre | 2 |
| 231 | gp-oxidase | 1 |
| 232 | 1,2,4-orthoacetylglucose | 1 |
| 233 | oxamate-agarose | 1 |
| 234 | tnf-sepharose | 1 |
| 235 | β-glycerolphosphate | 1 |
| 236 | meltdose-technique | 1 |
| 237 | 1.18-sieve | 1 |
| 238 | erythropoietin-hyporesponsive | 1 |
| 239 | instigative | 1 |
| 240 | 2mr-qff | 1 |
| 241 | tacrolimus-mmf | 4 |
| 242 | dna3'pp5'g | 3 |
| 243 | echo-ecg | 1 |
| 244 | per-ecg | 1 |
| 245 | adfi/adg | 1 |
| 246 | inflammageing | 1 |
| 247 | snicking | 2 |
| 248 | time-to-wound-healing | 1 |
| 249 | awakening | 431 |
| 250 | calcining | 2 |
| 251 | hypofractioning | 1 |
| 252 | underdoping | 1 |
| 253 | antibiotic-dispensing | 1 |
| 254 | room/nursing | 1 |
| 255 | partner-testing | 1 |
| 256 | design-copying | 1 |
| 257 | bandung | 3 |
| 258 | www.aawconline.org | 1 |
| 259 | www.oxynet.org | 1 |
| 260 | silkeborg | 3 |
| 261 | functional-reach | 1 |
| 262 | movement/cough | 1 |
| 263 | hcl/etoh | 1 |
| 264 | plaque-growth | 1 |
| 265 | hvlt-i | 1 |
| 266 | trbd-i-ii | 1 |
| 267 | iess-ii | 1 |
| 268 | m.robertsii | 1 |
| 269 | guglielmi | 1 |
| 270 | funding/coi | 1 |
| 271 | modeling/voi | 1 |
| 272 | 3.0tmri | 1 |
| 273 | candida-uti | 1 |
| 274 | tbl1wi | 3 |
| 275 | nnewi | 1 |
| 276 | corel5k | 1 |
| 277 | src/fak | 1 |
| 278 | www.cochrane.dk | 3 |
| 279 | travnik | 3 |
| 280 | admission/initial | 1 |
| 281 | preimplantational | 1 |
| 282 | maternal/paternal | 1 |
| 283 | corticosteroid-oral | 1 |
| 284 | arrival | 692 |
| 285 | sub-domain-level | 1 |
| 286 | p-crkl | 1 |
| 287 | cigarettes/alcohol | 1 |
| 288 | 1,3-propandiol | 1 |
| 289 | 1,3-dipalmitoyl-2-oleoyl-glycerol | 1 |
| 290 | balance-control | 1 |
| 291 | wl-furl | 1 |
| 292 | pczl | 1 |
| 293 | c.p.l.m | 1 |
| 294 | angiohistogram | 1 |
| 295 | bioautogram | 1 |
| 296 | 395nm | 1 |
| 297 | zocdoc.com | 1 |
| 298 | myspace.com | 1 |
| 299 | bmj.com | 4 |
| 300 | surrealism | 1 |
| 301 | entrepreneurialism | 1 |
| 302 | marx-leninism | 1 |
| 303 | 400n | 3 |
| 304 | chitin/chitosan | 1 |
| 305 | lanmen | 1 |
| 306 | pilsen | 2 |
| 307 | mk-7009+pegifn | 1 |
| 308 | lucidin | 1 |
| 309 | p-glycloprotein | 1 |
| 310 | mo-pyranopterin | 1 |
| 311 | clorin | 1 |
| 312 | torreon | 2 |
| 313 | cancer/union | 1 |
| 314 | dna-expression | 1 |
| 315 | admission | 8,317 |
| 316 | admission/readmission | 3 |
| 317 | reincubation | 3 |
| 318 | ethnoclassification | 1 |
| 319 | multi-regulation | 1 |
| 320 | acetylcholine-stimulation | 1 |
| 321 | pentagastrin-stimulation | 1 |
| 322 | palpation/manipulation | 1 |
| 323 | 25-hydroxylation | 2 |
| 324 | dehydration/dehydroxylation | 1 |
| 325 | seromaformation | 1 |
| 326 | culture-contamination | 1 |
| 327 | photoillumination | 2 |
| 328 | incarnation | 1 |
| 329 | gelfiltration | 1 |
| 330 | photoexcitation | 14 |
| 331 | pre-infestation | 1 |
| 332 | sympatho-activation | 1 |
| 333 | catherterization | 1 |
| 334 | crosssection | 1 |
| 335 | case-detection | 1 |
| 336 | reward/addiction | 1 |
| 337 | 5α-reduction | 3 |
| 338 | cystoreduction | 1 |
| 339 | viscerperception | 1 |
| 340 | fortison | 1 |
| 341 | gregorio | 5 |
| 342 | kloo | 1 |
| 343 | i.v.p | 1 |
| 344 | a375p | 2 |
| 345 | tcp/ip | 1 |
| 346 | 3'amp | 1 |
| 347 | gpm/grp | 1 |
| 348 | bitter-cup | 1 |
| 349 | 21q | 1 |
| 350 | chr17q | 1 |
| 351 | vaniprevir/p/r | 1 |
| 352 | births/year | 2 |
| 353 | panlobular | 1 |
| 354 | local/vernacular | 1 |
| 355 | physical-cardiovascular | 1 |
| 356 | stoppler | 1 |
| 357 | trainee-trainer | 1 |
| 358 | veloergometer | 1 |
| 359 | flhclabor | 1 |
| 360 | opsr | 1 |
| 361 | 3bs | 1 |
| 362 | pseudobulbs | 2 |
| 363 | macroeconomics | 1 |
| 364 | biothermokinetics | 1 |
| 365 | benzodiazepines/hypnotics | 1 |
| 366 | pharmacognostics | 1 |
| 367 | housemaids | 1 |
| 368 | ophiuroids | 1 |
| 369 | lipoproteins/lipids | 1 |
| 370 | weekends | 109 |
| 371 | nights/weekends | 1 |
| 372 | mg-compounds | 1 |
| 373 | skateboards | 1 |
| 374 | admittances | 9 |
| 375 | prevalences/incidences | 1 |
| 376 | fibrocartilages | 1 |
| 377 | mlo-images | 1 |
| 378 | folk-categories | 1 |
| 379 | macroscales | 1 |
| 380 | slacklines | 1 |
| 381 | waterlines | 3 |
| 382 | tiptoes | 1 |
| 383 | iciq-scores | 1 |
| 384 | hot-melt-extrudates | 1 |
| 385 | lisinopril-nitrates | 4 |
| 386 | driver-athletes | 1 |
| 387 | israelites | 1 |
| 388 | dha-metabolites | 1 |
| 389 | cd14+-monocytes | 1 |
| 390 | intentions/motives | 1 |
| 391 | esrfs | 1 |
| 392 | alcohol/drugs | 4 |
| 393 | 'deaths | 4 |
| 394 | 2,3-bdo-biosynthesis | 1 |
| 395 | hematogenesis | 1 |
| 396 | acetogenesis | 1 |
| 397 | atheroslocerosis | 1 |
| 398 | neuroacanthocytosis | 1 |
| 399 | endonucleolysis | 1 |
| 400 | sonolysis | 5 |
| 401 | unguis | 2 |
| 402 | cmv-prophylaxis | 1 |
| 403 | typicals | 4 |
| 404 | ttr-levels | 1 |
| 405 | macrophages/neutrophils | 1 |
| 406 | polyalcohols | 1 |
| 407 | uplc-dad/q-tof-ms | 1 |
| 408 | gc/tofms | 1 |
| 409 | copd-symptoms | 1 |
| 410 | landforms | 1 |
| 411 | beauticians | 1 |
| 412 | reptilians | 1 |
| 413 | cubozoans | 2 |
| 414 | floodplains | 1 |
| 415 | admissions | 2,399 |
| 416 | pre-travel-vaccinations | 1 |
| 417 | brca-mutations | 1 |
| 418 | cmv-infections | 1 |
| 419 | ffpe-sections | 1 |
| 420 | injured-neurons | 1 |
| 421 | troopships | 2 |
| 422 | cryotops | 1 |
| 423 | chemist/engineers | 1 |
| 424 | mangers | 1 |
| 425 | traditionalhealers | 1 |
| 426 | microcontrollers | 1 |
| 427 | nmda-receptors | 2 |
| 428 | alloresponsiveness | 1 |
| 429 | motion/tenderness | 1 |
| 430 | weightloss | 1 |
| 431 | panss-pss | 1 |
| 432 | e-/ts | 1 |
| 433 | skin-grafts | 1 |
| 434 | four-month-infants | 1 |
| 435 | s-components | 1 |
| 436 | sylvanus | 2 |
| 437 | pten/p53status | 1 |
| 438 | itch/pruritus | 2 |
| 439 | mondays | 14 |
| 440 | sundays | 4 |
| 441 | saturdays/sundays | 1 |
| 442 | saturdays | 10 |
| 443 | tuesdays | 1 |
| 444 | thursdays | 5 |
| 445 | hs700t | 1 |
| 446 | sprat | 2 |
| 447 | met-diet | 5 |
| 448 | hdm-ait | 1 |
| 449 | uvo-treatment | 1 |
| 450 | non-competent | 1 |
| 451 | stable-art | 1 |
| 452 | low-effort | 1 |
| 453 | dbest | 2 |
| 454 | gallnut | 1 |
| 455 | o'ahu | 1 |
| 456 | 30w | 1 |
| 457 | 8-lox | 2 |
| 458 | linux | 1 |
| 459 | h-day | 1 |
| 460 | delay/nondelay | 1 |
| 461 | length-of-stay | 40 |
| 462 | higher-frequency | 2 |
| 463 | maconkey | 1 |
| 464 | neuroimmunopharmacology | 1 |
| 465 | alzheimer-pathology | 1 |
| 466 | cytology/pathology | 1 |
| 467 | hysterosonography | 1 |
| 468 | heteropathy | 1 |
| 469 | nefhropathy | 1 |
| 470 | respectiverly | 1 |
| 471 | 'sympathectomy | 1 |
| 472 | salt/nephrectomy | 1 |
| 473 | dejguny | 1 |
| 474 | 'psychopharmacotherapy | 1 |
| 475 | darunavir/monotherapy | 1 |
| 476 | aerotherapy | 1 |
| 477 | atherosclerosis-safety | 1 |
| 478 | hyperspasticity | 1 |
| 479 | typability | 1 |
| 480 | marketability | 1 |
| 481 | need/acceptability | 1 |
| 482 | sensitivity/acceptability | 1 |
| 483 | anti-senility | 1 |
| 484 | neuroactivity | 1 |
| 485 | stai-jyz | 1 |
| 486 | dysco₃ | 1 |
| 487 | ifn-τ | 1 |
| 488 | 14-3-3χ | 1 |
| 489 | ifnß | 1 |
| 490 | extrelut® | 1 |
| 491 | pka/pkcε | 1 |